Answers are grounded in this paper and cite their sources.
Although dual-activity agents remain the keystone for treatment, newer drugs and drug-delivery systems offer other novel directions for delivering appropriate relief with minimal adverse effects.
No takes yet. Share an insight, caveat, or question.
Kimchi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: